Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Neoplasms, Squamous Cell 1Neoplasms 1Lung Neoplasms 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 53pembrolizumab 51Carboplatin 51Magnetic Resonance Spectroscopy 46Pemetrexed 41Cisplatin 36Paclitaxel 25durvalumab 24osimertinib 22Nivolumab 22Gemcitabine 20Radiosurgery 18Radiotherapy 17Docetaxel 17atezolizumab 15Immunoglobulin G 15Biopsy 15Disulfides 14130-nm albumin-bound paclitaxel 13Taxes 12Radiation 12Educational Status 12Etoposide 11Blood Specimen Collection 11Early Intervention, Educational 10Drug Therapy 10Practice Guidelines as Topic 9Platinum 9Methods 9Cetuximab 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Neoplasms × Biological Products × 90 days × Clear all
NCT04908111 2026-04-06

A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1

Cancer Research UK

Phase 1/2 Suspended
15 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Lung Neoplasms, Neoplasms, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡